{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:17:11Z","timestamp":1791494231307,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003851","name":"education department of Heilongjiang province","doi-asserted-by":"crossref","award":["2017YFD0501102"],"award-info":[{"award-number":["2017YFD0501102"]}],"id":[{"id":"10.13039\/501100003851","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D program of China","doi-asserted-by":"crossref","award":["2017YFD0501103-03"],"award-info":[{"award-number":["2017YFD0501103-03"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11033-021-06707-0","type":"journal-article","created":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T04:02:21Z","timestamp":1631937741000},"page":"7153-7163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["FGF21 ameliorates hepatic fibrosis by multiple mechanisms"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6231-6639","authenticated-orcid":false,"given":"Fanrui","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir Hassan","family":"Khoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukai","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,18]]},"reference":[{"issue":"3","key":"6707_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.molmet.2013.12.003","volume":"3","author":"A Kharitonenkov","year":"2014","unstructured":"Kharitonenkov A, Adams AC (2014) Inventing new medicines: the FGF21 story. Mol Metab 3(3):221\u2013229","journal-title":"Mol Metab"},{"key":"6707_CR2","doi-asserted-by":"crossref","unstructured":"Nobuyuki, Itoh. FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases. Frontiers in Endocrinology. 5(2):p.152\u2013159, (2014).","DOI":"10.3389\/fendo.2014.00107"},{"key":"6707_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","volume":"148","author":"PA Dutchak","year":"2012","unstructured":"Dutchak PA, Katafuchi T, Bookout AL et al (2012) Fibroblast growth factor-21 regulates PPAR\u03b3 activity and the antidiabetic actions of thiazolidinediones. Cell 148:556\u2013567","journal-title":"Cell"},{"issue":"9","key":"6707_CR4","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1210\/en.2009-0221","volume":"150","author":"ED Berglund","year":"2009","unstructured":"Berglund ED, Li CY, Bina HA et al (2009) Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity. Endocrinology. 150(9):4084\u20134093","journal-title":"Endocrinology."},{"issue":"21","key":"6707_CR5","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1161\/CIRCULATIONAHA.115.015308","volume":"131","author":"Z Lin","year":"2015","unstructured":"Lin Z, Pan X, Wu F et al (2015) Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice. Circulation 131(21):1861\u20131871","journal-title":"Circulation"},{"key":"6707_CR6","first-page":"1241","volume":"6","author":"S Li","year":"1865","unstructured":"Li S, Zhu Z, Xue M et al (1865) (2019) Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1. Biochimica et Biophysica Acta (BBA) 6:1241\u20131252","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"6","key":"6707_CR7","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.cmet.2018.04.002","volume":"27","author":"X Pan","year":"2018","unstructured":"Pan X, Shao Y, Wu F et al (2018) FGF21 Prevents angiotensin II-Induced hypertension and vascular dysfunction by activation of ACE2\/angiotensin-(1\u20137) axis in mice. Cell Metab 27(6):1323\u20131337","journal-title":"Cell Metab"},{"issue":"1\u20132","key":"6707_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11010-014-2044-0","volume":"393","author":"X Lin","year":"2014","unstructured":"Lin X, Li G, He X et al (2014) FGF21 inhibits apolipoprotein(a) expression in HepG2 cells via the FGFR1-ERK1\/2-Elk-1 pathway. Mol Cell Biochem 393(1\u20132):33\u201342","journal-title":"Mol Cell Biochem"},{"key":"6707_CR9","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1007\/s10620-015-3711-z","volume":"60","author":"P Xu","year":"2015","unstructured":"Xu P, Zhang Y, Wang W et al (2015) Long-term administration of fibroblast growth factor 21 prevents chemically-induced hepatocarcinogenesis in mice. Digest Dis Sci 60:3032\u20133043","journal-title":"Digest Dis Sci"},{"key":"6707_CR10","first-page":"567","volume":"19","author":"YK Opoku","year":"2020","unstructured":"Opoku YK et al (2020) Fibroblast growth factor-21 ameliorates hepatic encephalopathy by activating the stat3-socs3 pathway to inhibit activated hepatic stellate cells. EXCLJ J 19:567\u2013581","journal-title":"EXCLJ J"},{"key":"6707_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.taap.2015.11.012","volume":"290","author":"P Xu","year":"2016","unstructured":"Xu P, Zhang Y, Wang W (2016) Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-\u03b2\/smad2\/3 and NF-\u03baB signaling pathways. Toxicol Appl Pharmacol 290:43\u201353","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"6707_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.5009\/gnl17443","volume":"12","author":"KJ Lee","year":"2018","unstructured":"Lee KJ, Jang YO, Cha SK et al (2018) Expression of fibroblast growth factor 21 and \u03b2-klotho regulates hepatic fibrosis through the nuclear factor-\u03baB and c-Jun N-terminal kinase pathways. Gut Liver 12(4):449\u2013456","journal-title":"Gut Liver"},{"issue":"1","key":"6707_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5152\/tjg.2018.17330","volume":"29","author":"MM Aydin","year":"2018","unstructured":"Aydin MM, Akcali KC (2018) Liver fibrosis. Turk J Gastroenterol 29(1):14\u201321","journal-title":"Turk J Gastroenterol"},{"issue":"2","key":"6707_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Investig 115(2):209\u2013218","journal-title":"J Clin Investig"},{"issue":"9","key":"6707_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/qjmed\/hcs069","volume":"105","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran P, Iredale JP (2012) Liver fibrosis: a bidirectional model of fibrogenesis and resolution. QJM 105(9):813\u2013817","journal-title":"QJM"},{"issue":"7","key":"6707_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL (2017) Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 14(7):397\u2013411","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"48","key":"6707_CR17","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","volume":"22","author":"C Zhang","year":"2016","unstructured":"Zhang C et al (2016) Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol 22(48):10512","journal-title":"World J Gastroenterol"},{"issue":"13","key":"6707_CR18","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1096\/fj.04-1847fje","volume":"18","author":"NK Saxena","year":"2004","unstructured":"Saxena NK et al (2004) Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J 18(13):1612\u20131614","journal-title":"FASEB J"},{"issue":"2","key":"6707_CR19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/jcm9020560","volume":"9","author":"I Kouta","year":"2020","unstructured":"Kouta I, Mrzljak A, Kolari B et al (2020) Leptin as a key player in insulin resistance of liver cirrhosis? A cross-sectional study in liver transplant candidates. J Clin Med 9(2):560","journal-title":"J Clin Med"},{"issue":"3","key":"6707_CR20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1124\/jpet.118.256156","volume":"370","author":"Z Chen","year":"2019","unstructured":"Chen Z, Jain A, Liu H et al (2019) Targeted drug delivery to hepatic stellate cells for the treatment of liver fibrosis. J Pharmacol Exp Ther 370(3):695\u2013702","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"6707_CR21","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","volume":"90","author":"SC Yanguas","year":"2016","unstructured":"Yanguas SC, Cogliati B, Eillebrods J (2016) Experimental models of liver fibrosis. Arch Toxicol 90(5):1025\u20131048","journal-title":"Arch Toxicol"},{"issue":"1","key":"6707_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0023677215571192","volume":"49","author":"D Scholten","year":"2015","unstructured":"Scholten D, Trebicka J, Liedtke C et al (2015) The carbon tetrachloride model in mice. Lab Anim 49(1):4\u201311","journal-title":"Lab Anim"},{"key":"6707_CR23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/0041-008X(72)90255-4","volume":"22","author":"GO Korsrud","year":"1972","unstructured":"Korsrud GO, Harold C et al (1972) Sensitivity of several serum enzymes in detecting carbon tetrachloride-induced liver damage in rats. Toxicol Appl Pharmacol 22:474\u2013483","journal-title":"Toxicol Appl Pharmacol"},{"key":"6707_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0163-7258(96)00062-9","volume":"71","author":"L Verna","year":"1996","unstructured":"Verna L, Whysner J, Williams GM (1996) N-Nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 71:57\u201381","journal-title":"Pharmacol Ther"},{"issue":"22","key":"6707_CR25","doi-asserted-by":"publisher","first-page":"1700267","DOI":"10.1002\/pmic.201700267","volume":"17","author":"X Liu","year":"2017","unstructured":"Liu X, Dai R, Ke M et al (2017) Differential proteomic analysis of dimethylnitrosamine (DMN)-induced liver fibrosis. Proteomics 17(22):1700267","journal-title":"Proteomics"},{"issue":"1","key":"6707_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41419-018-1272-8","volume":"10","author":"J George","year":"2019","unstructured":"George J, Tsuchishima M, Tsutsumi M (2019) Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis. Cell Death Dis 10(1):52\u201359","journal-title":"Cell Death Dis"},{"key":"6707_CR27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fmed.2015.00072","volume":"2","author":"F Van Dijk","year":"2015","unstructured":"Van Dijk F et al (2015) Targeted therapies in liver fibrosis: combining the best parts of platelet-derived growth factor BB and interferon gamma. Front Med 2:257\u2013260","journal-title":"Front Med"},{"issue":"6","key":"6707_CR28","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134(6):1655\u20131669","journal-title":"Gastroenterology"},{"issue":"14","key":"6707_CR29","doi-asserted-by":"publisher","first-page":"10551","DOI":"10.1016\/S0021-9258(17)34095-4","volume":"269","author":"SL Friedman","year":"1994","unstructured":"Friedman SL, Yamasaki G, Wong L (1994) Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. J Biol Chem 269(14):10551\u201310558","journal-title":"J Biol Chem"},{"key":"6707_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cytogfr.2015.10.002","volume":"28","author":"E Borkham-Kamphorst","year":"2016","unstructured":"Borkham-Kamphorst E, Weiskirchen R (2016) The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev 28:53\u201361","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"6707_CR31","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s10620-006-9126-0","volume":"51","author":"SK Bethanis","year":"2006","unstructured":"Bethanis SK, Theocharis SE (2006) Leptin in the field of hepatic fibrosis: a pivotal or an incidental player? Dig Dis Sci 51(10):1685\u20131696","journal-title":"Dig Dis Sci"},{"issue":"7","key":"6707_CR32","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00018-016-2133-1","volume":"73","author":"O Kwon","year":"2016","unstructured":"Kwon O, Kim KW, Kim M (2016) Leptin signaling pathways in hypothalamic neurons. Cell Mol Life Sci 73(7):1457\u20131477","journal-title":"Cell Mol Life Sci"},{"key":"6707_CR33","first-page":"123","volume":"20","author":"GS Sahin","year":"2019","unstructured":"Sahin GS, Dhar M, Dillon C (2019) leptin stimulates synaptogenesis in hippocapal nerons via KLF4 and SOCS3 inhibition of STAT3 signaling. Mol Cell Neurosci 20:123\u2013128","journal-title":"Mol Cell Neurosci"},{"issue":"9","key":"6707_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.tem.2006.09.007","volume":"17","author":"JK Howard","year":"2006","unstructured":"Howard JK, Flier JS (2006) Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab 17(9):365\u2013370","journal-title":"Trends Endocrinol Metab"},{"issue":"12","key":"6707_CR35","doi-asserted-by":"publisher","first-page":"640","DOI":"10.5483\/BMBRep.2020.53.12.161","volume":"53","author":"GY Kim","year":"2020","unstructured":"Kim GY, Jeong H, Yoon H-M (2020) Anti-inflammatory mechanisms of suppressors of cytokine signaling target ROS via NRF-2\/thioredoxin induction and inflammasome activation in macrophages. BMB Rep 53(12):640\u2013645","journal-title":"BMB Rep"},{"key":"6707_CR36","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.biopha.2018.03.100","volume":"103","author":"S Zhang","year":"2018","unstructured":"Zhang S et al (2018) FGF21 attenuates pulmonary fibrogenesis through ameliorating oxidative stress in vivo and in vitro. Biomed Pharmacother 103:1516\u20131525","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"6707_CR37","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.transproceed.2008.07.040","volume":"40","author":"JH Jang","year":"2008","unstructured":"Jang JH, Kang KJ, Kim YH et al (2008) Reevaluation of experimental model of hepatic fibrosis induced by hepatotoxic drugs: an easy, applicable, and reproducible model. Transpl Proc 40(8):2700\u20132703","journal-title":"Transpl Proc"},{"issue":"5","key":"6707_CR38","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/emboj\/18.5.1280","volume":"18","author":"X Yang","year":"1999","unstructured":"Yang X, Lechleider RJ, Chen L et al (1999) Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 18(5):1280\u20131291","journal-title":"EMBO J"},{"issue":"3","key":"6707_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ygcen.2011.10.001","volume":"175","author":"S Trombley","year":"2012","unstructured":"Trombley S, Maugars G, Kling P et al (2012) Effects of long-term restricted feeding on plasma leptin, hepatic leptin expression and leptin receptor expression in juvenile Atlantic salmon (Salmo salar L.). Gen Comp Endocrinol 175(3):92\u201399","journal-title":"Gen Comp Endocrinol"},{"issue":"01","key":"6707_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1055\/s-2004-815720","volume":"112","author":"C Otte","year":"2004","unstructured":"Otte C, Otte JM et al (2004) Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis. Exp Clin Endocrinol Diabetes 112(01):10\u201317","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"11","key":"6707_CR41","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.3390\/ijms20112700","volume":"20","author":"B Foglia","year":"2019","unstructured":"Foglia B, Cannito S, Bocca C et al (2019) ERK pathway in activated, myofibroblast-like, hepatic stellate cells: a critical signaling crossroad sustaining liver fibrosis. Int J Mol Sci 20(11):2700","journal-title":"Int J Mol Sci"},{"key":"6707_CR42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.intimp.2017.06.001","volume":"49","author":"C Lu","year":"2017","unstructured":"Lu C et al (2017) Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2\/STAT3 signaling in hepatic stellate cells. Int Immunopharmacol 49:203\u2013211","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"6707_CR43","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/jcb.29378","volume":"121","author":"Z Gong","year":"2019","unstructured":"Gong Z, Lin J, Zheng J et al (2019) Dahuang Zhechong pill attenuates CCl4-induced rat liver fibrosis via the PI3K-Akt signaling pathway. J Cell Biochem 121(2):1431\u20131440","journal-title":"J Cell Biochem"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06707-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06707-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06707-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T18:24:23Z","timestamp":1675707863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06707-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,18]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["6707"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06707-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,18]]},"assertion":[{"value":"18 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of Northeast Agriculture University. All experimental protocols followed the guidelines issued by National Institute of Health and the Institutional Animal Care and Use Committee of Northeast Agriculture University. The mice were euthanatized under anesthesia induced by intraperitoneal injection of 1.2% avertin (Sigma, USA) at a dose of 20\u00a0\u03bcL\/g body weight.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}